Tag: cvrx
CVRx announces initiation of BENEFIT-HF trial of Barostim device in “significantly expanded population”
CVRx recently announced the start of the BENEFIT-HF clinical trial, a randomised study designed ...
CVRx launches new version of neuromodulation device intended to treat heart failure
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodula...
FDA approves new device to improve symptoms in patients with advanced heart failure
The US Food and Drug Administration has approved the Barostim Neo system for the improvement of ...
New vice president of US market development for CVRx
CVRx has appointed Tom Moore to the newly created, officer position of vice president, US Market...
